Probiotics and Antimicrobial Proteins Микробиология
Engineering Microencapsulated Probiotics for Enhanced Aflatoxin M1 Mitigation in Milk
Аннотация
Aflatoxin M_1 is a major mycotoxin found primarily in milk and dairy products that causes a severe public health risk to dairy product safety and the dairy industry. Therefore, the present study explored the effectiveness of micro-encapsulated Lactobacillus acidophilus , Lactobacillus Casei and Bifidobacterium bifidum in reducing AFM_1 in milk as promising and emerging strategies for eliminating and controlling AFM1 in milk. Nonetheless, it is challenging to maintain a high number of live cells in probiotic foods during storage and gastrointestinal transit. Microencapsulation of probiotic bacteria is an efficient approach to increase probiotic viability by minimizing cell exposure to harsh environments via the gastrointestinal tract before releasing them into the colon. Hence, Lactobacillus Casei , Lactobacillus acidophilus and Bifidobacterium bifidum were encapsulated with ionic gelation techniques in alginate/inulin microcapsules (LC/AL/IN), (LA/AL/IN), and (BB/AL/IN), with encapsulation yields of 87.5 ± 0.50%, 90.3 ± 0.71%, and 83.2 ± 0.33%, respectively. The morphology of the microcapsules was investigated with a scanning electron microscope. The encapsulation yield, particle size, zeta potential, and FTIR were investigated for the prepared microcapsule. The effect of (LC/AL/IN), (LA/AL/IN), and BB/AL/IN alone and their combined mixture was tested for mitigation of aflatoxin M1 in artificially contaminated milk with a reduction percentage of 91%, 91%, 76%, and 95.66%, respectively. These findings suggested that microencapsulated probiotics represent a safe and effective strategy for AFM1 management with a strong ability to decrease AFM1 in milk.